m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00510
|
[1], [2], [3], [4] | |||
: modification sites
Indirect
Enhancement
m6A modification
PTEN
PTEN
IGF2BP1
: m6A sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) | READER | |||
| m6A Target | Mutated in multiple advanced cancers 1 (PTEN) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> Adenosine-to-Inosine editing (A-to-I) | ||||
| Epigenetic Regulator | Interferon-inducible protein 4 (ADAR1) | WRITER | View Details | ||
| Regulated Target | hsa-mir-18a | View Details | |||
| Crosstalk Relationship | A-to-I → m6A | Enhancement | |||
| Crosstalk Mechanism | RNA modification indirectly impacts m6A modification through downstream signaling pathways | ||||
| Crosstalk Summary | ADAR1 interacts with hsa-mir-18a, increasing it's A-to-I level and promoting its physical interaction with Mutated in multiple advanced cancers 1 (PTEN), which was regulated by IGF2BP1-mediated m6A modification. | ||||
In-vitro Model |
U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 | |
| U-87MG ATCC | Glioblastoma | Homo sapiens | CVCL_0022 | ||
| U-373MG ATCC | Astrocytoma | Homo sapiens | CVCL_2219 | ||
| CAL-27 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1107 | ||
| HN4 | Clear cell renal cell carcinoma | Homo sapiens | CVCL_IS30 | ||
References
: modification sites
: m6A sites